SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 810.47 |
| Enterprise Value ($M) | 683.47 |
| Book Value ($M) | 292.48 |
| Book Value / Share | 1.31 |
| Price / Book | 2.77 |
| NCAV ($M) | -56.77 |
| NCAV / Share | -0.25 |
| Price / NCAV | -14.28 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.79 |
| Return on Assets (ROA) | -0.54 |
| Return on Equity (ROE) | -1.06 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.47 |
| Current Ratio | 4.47 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 210.15 |
| Assets | 559.39 |
| Liabilities | 266.91 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | ARCH Venture Fund IX, L.P. | 20.60 | 4.27 | |
| 13G/A | Canada Pension Plan Investment Board | 4.60 | 0.00 | |
| 13G/A | Fmr Llc | 14.21 | 42.59 | |
| 13G/A | Vanguard Group Inc | 5.92 | 0.00 | |
| 13G | BlackRock, Inc. | 5.30 | 0.00 | |
| 13G/A | Baillie Gifford & Co | 4.70 | 2.07 | |
| 13G/A | Flagship Ventures Fund V, L.P. | 13.00 | -25.28 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 3,025,927 | 9,310,571 | 32.50 | |
| 2,726,167 | 9,293,340 | 29.33 | |
| 3,288,251 | 11,669,076 | 28.18 | |
| 7,557,124 | 24,382,597 | 30.99 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RPTX – Repare Therapeutics Inc. | RVMD – Revolution Medicines, Inc. |
| RXRX – Recursion Pharmaceuticals, Inc. | SCPH – scPharmaceuticals Inc. |
| SDGR – Schrödinger, Inc. |
Financial data and stock pages provided by
Fintel.io